Menu
Back to User profile » Dr Satohiro Matsumoto
Papers published by Dr Satohiro Matsumoto:
Successful Fistula Closure After Treatment with Colostomy and Infliximab in a Patient with Ulcerative Colitis Complicated by Rectovaginal Fistula
Katsube S, Matsumoto S, Misawa M, Kakizawa N, Hashimoto R, Mizutani T, Matsumoto K, Yoshikawa S, Mashima H
Biologics: Targets and Therapy 2024, 18:107-113
Published Date: 6 May 2024
Efficacy of Anti-Tumor Necrosis Factor-α Therapy Against Intestinal Behçet’s Disease Complicated by Recurrent Enterocutaneous Fistulae
Kashima H, Matsumoto S, Kojima S, Koito Y, Miura T, Ishii T, Mashima H
Biologics: Targets and Therapy 2022, 16:1-6
Published Date: 2 February 2022
Efficacy of Ustekinumab Against Spondyloarthritis Associated with Crohn’s Disease: A Case Report and Review of the Literature
Matsumoto S, Matsumoto K, Takaya H, Otake H, Mashima H
Open Access Rheumatology: Research and Reviews 2020, 12:133-137
Published Date: 29 July 2020
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
Matsumoto S, Mashima H
Biologics: Targets and Therapy 2018, 12:69-73
Published Date: 19 July 2018
Tacrolimus versus anti-tumor necrosis factor agents for steroid-refractory active ulcerative colitis based on the severity of endoscopic findings: a single-center, open-label cohort study
Matsumoto S, Kawamura H, Nishikawa T, Sagihara N, Miyatani H, Mashima H
Clinical and Experimental Gastroenterology 2017, 10:249-258
Published Date: 26 September 2017
Efficacy of a pH-dependent controlled-release mesalazine based on clinical and endoscopic assessment for ulcerative colitis: a retrospective cohort study
Matsumoto S, Yoshida Y
Clinical and Experimental Gastroenterology 2015, 8:225-230
Published Date: 31 July 2015